Background and Purpose: Mu opioid receptors (MORs) are expressed in the
dorsal striatum, a brain region that mediates goal-directed (via the
dorsomedial striatum), and habitual (via the dorsolateral striatum, DLS)
behaviors. Our previous work indicates that glutamate transmission is
depressed when MORs are activated in the dorsal striatum, inducing
MOR-mediated long-term synaptic depression (MOR-LTD) or short-term
depression (MOR-STD), depending on the input. In the DLS, MOR-LTD is
produced by MORs on anterior insular cortex (AIC) inputs and MOR-STD
occurs at thalamic inputs, suggesting input-specific MOR plasticity
mechanisms. Experimental Approach: We evaluated the mechanisms of
induction of MOR-LTD and MOR-STD in the DLS using pharmacology and
optogenetics combined with patch clamp electrophysiology. To evaluate
glutamatergic synapses, we used C57BL/6J (all glutamatergic inputs or
targeted probing of AIC-DLS inputs), Emx1-Ai32 (cortical inputs),
VGluT2-Ai32 (thalamic inputs) and HCN1-flox (AIC-DLS HCN1 deletion)
mice. Key Results: We found that cAMP/PKA signaling and protein
synthesis are necessary for MOR-LTD expression, similar to previous
studies of endocannabinoid-mediated LTD (eCB-LTD) in DLS. However,
MOR-LTD does not require mTOR signaling as eCB-LTD does. MOR-STD does
not utilize these same mechanisms. We characterized a novel role of
presynaptic HCN1 channels in MOR-LTD induction as HCN1 channels
expressed in AIC are necessary for MOR-LTD expression in the DLS.
Conclusion and Implications: These results show a novel mechanism in
which MOR activation needs HCN1 to induce MOR-LTD, suggesting a new
target for pharmacological modulation of synaptic plasticity, providing
new opportunities to develop novel drugs to treat alcohol and opioid use
disorders.